Department of Clinical Infection,
Microbiology and Immunology,
Institute of Infection,
Veterinary and Ecological Sciences (IVES),
Department of Clinical Infection, Microbiology and Immunology, Institute of Infection, Veterinary and Ecological Sciences (IVES),
Department of Clinical Infection, Microbiology and Immunology
Joanne L. Fothergill has not added Biography.
If you are Joanne L. Fothergill and would like to personalize this page please email our Author Liaison for assistance.
Widespread pyocyanin over-production among isolates of a cystic fibrosis epidemic strain.
BMC microbiology , 2007 | Pubmed ID: 17521417
Diagnostic multiplex PCR assay for the identification of the Liverpool, Midlands 1 and Manchester CF epidemic strains of Pseudomonas aeruginosa.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society May, 2008 | Pubmed ID: 18029234
The role of quorum sensing in chronic cystic fibrosis Pseudomonas aeruginosa infections.
FEMS microbiology letters Jan, 2009 | Pubmed ID: 19016870
Newly introduced genomic prophage islands are critical determinants of in vivo competitiveness in the Liverpool Epidemic Strain of Pseudomonas aeruginosa.
Genome research Jan, 2009 | Pubmed ID: 19047519
Fluctuations in phenotypes and genotypes within populations of Pseudomonas aeruginosa in the cystic fibrosis lung during pulmonary exacerbations.
Journal of medical microbiology Apr, 2010 | Pubmed ID: 20019149
Empyema due to a highly transmissible Pseudomonas aeruginosa strain in an adult cystic fibrosis patient.
Journal of medical microbiology May, 2010 | Pubmed ID: 20133415
Impact of Pseudomonas aeruginosa genomic instability on the application of typing methods for chronic cystic fibrosis infections.
Journal of clinical microbiology Jun, 2010 | Pubmed ID: 20410349
Effect of antibiotic treatment on bacteriophage production by a cystic fibrosis epidemic strain of Pseudomonas aeruginosa.
Antimicrobial agents and chemotherapy Jan, 2011 | Pubmed ID: 20974862
Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections.
American journal of respiratory and critical care medicine Jun, 2011 | Pubmed ID: 21297072
Transmissible strains of Pseudomonas aeruginosa in cystic fibrosis lung infections.
The European respiratory journal Jul, 2012 | Pubmed ID: 22323572
Novel therapeutic strategies to counter Pseudomonas aeruginosa infections.
Expert review of anti-infective therapy Feb, 2012 | Pubmed ID: 22339195
Differential infection properties of three inducible prophages from an epidemic strain of Pseudomonas aeruginosa.
BMC microbiology Sep, 2012 | Pubmed ID: 22998633
Intraclonal genetic diversity amongst cystic fibrosis and keratitis isolates of Pseudomonas aeruginosa.
Journal of medical microbiology Feb, 2013 | Pubmed ID: 23105019
Extensive diversification is a common feature of Pseudomonas aeruginosa populations during respiratory infections in cystic fibrosis.
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society Dec, 2013 | Pubmed ID: 23642644
Sub-inhibitory concentrations of some antibiotics can drive diversification of Pseudomonas aeruginosa populations in artificial sputum medium.
BMC microbiology Jul, 2013 | Pubmed ID: 23879797
Comparative genomics of isolates of a Pseudomonas aeruginosa epidemic strain associated with chronic lung infections of cystic fibrosis patients.
PloS one , 2014 | Pubmed ID: 24505294
The B lymphocyte differentiation factor (BAFF) is expressed in the airways of children with CF and in lungs of mice infected with Pseudomonas aeruginosa.
PloS one , 2014 | Pubmed ID: 24847941
Pseudomonas aeruginosa adaptation in the nasopharyngeal reservoir leads to migration and persistence in the lungs.
Nature communications Sep, 2014 | Pubmed ID: 25179232
Turnover of strains and intraclonal variation amongst Pseudomonas aeruginosa isolates from paediatric CF patients.
Diagnostic microbiology and infectious disease Dec, 2014 | Pubmed ID: 25284374
Lytic activity by temperate phages of Pseudomonas aeruginosa in long-term cystic fibrosis chronic lung infections.
The ISME journal Jun, 2015 | Pubmed ID: 25461970
Genes Required for Free Phage Production are Essential for Pseudomonas aeruginosa Chronic Lung Infections.
The Journal of infectious diseases Feb, 2016 | Pubmed ID: 26268854
Clinical utilization of genomics data produced by the international Pseudomonas aeruginosa consortium.
Frontiers in microbiology , 2015 | Pubmed ID: 26483767
The role of temperate bacteriophages in bacterial infection.
FEMS microbiology letters Mar, 2016 | Pubmed ID: 26825679
Temperate phages both mediate and drive adaptive evolution in pathogen biofilms.
Proceedings of the National Academy of Sciences of the United States of America Jul, 2016 | Pubmed ID: 27382184
High virulence sub-populations in Pseudomonas aeruginosa long-term cystic fibrosis airway infections.
BMC microbiology Feb, 2017 | Pubmed ID: 28158967
adaptation and diversification in the non-cystic fibrosis bronchiectasis lung.
The European respiratory journal Apr, 2017 | Pubmed ID: 28446558
The contribution of Pseudomonas aeruginosa virulence factors and host factors in the establishment of urinary tract infections.
FEMS microbiology letters Aug, 2017 | Pubmed ID: 28605563
The role of multispecies social interactions in shaping Pseudomonas aeruginosa pathogenicity in the cystic fibrosis lung.
FEMS microbiology letters Aug, 2017 | Pubmed ID: 28859314
Transmission and lineage displacement drive rapid population genomic flux in cystic fibrosis airway infections of a Pseudomonas aeruginosa epidemic strain.
Microbial genomics Mar, 2018 | Pubmed ID: 29547097
Genomic characterisation of an international Pseudomonas aeruginosa reference panel indicates that the two major groups draw upon distinct mobile gene pools.
FEMS microbiology letters Jul, 2018 | Pubmed ID: 29897457
Evolutionary trade-offs associated with loss of PmrB function in host-adapted Pseudomonas aeruginosa.
Nature communications Jul, 2018 | Pubmed ID: 29980663
Nitric Oxide Releasing Polymeric Coatings for the Prevention of Biofilm Formation.
Polymers Nov, 2017 | Pubmed ID: 30965904
Reservoirs of resistance: polymyxin resistance in veterinary-associated companion animal isolates of .
The Veterinary record Aug, 2019 | Pubmed ID: 31239295
Effect of Polymer Demixed Nanotopographies on Bacterial Adhesion and Biofilm Formation.
Polymers Nov, 2019 | Pubmed ID: 31766551
A megaplasmid family driving dissemination of multidrug resistance in Pseudomonas.
Nature communications Mar, 2020 | Pubmed ID: 32170080
The clinical and microbiological utility of inhaled aztreonam lysine for the treatment of acute pulmonary exacerbations of cystic fibrosis: An open-label randomised crossover study (AZTEC-CF).
Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society Nov, 2021 | Pubmed ID: 33358119
Transmission, adaptation and geographical spread of the Liverpool epidemic strain.
Microbial genomics Mar, 2021 | Pubmed ID: 33720817
The Building Blocks of Antimicrobial Resistance in : Implications for Current Resistance-Breaking Therapies.
Frontiers in cellular and infection microbiology , 2021 | Pubmed ID: 33937104
Bacterial keratitis: identifying the areas of clinical uncertainty.
Progress in retinal and eye research Jul, 2022 | Pubmed ID: 34915112
Pseudomonas aeruginosa utilizes the host-derived polyamine spermidine to facilitate antimicrobial tolerance.
JCI insight Nov, 2022 | Pubmed ID: 36194492
Development of liquid culture media mimicking the conditions of sinuses and lungs in cystic fibrosis and health.
F1000Research , 2022 | Pubmed ID: 36519007
Challenges and opportunities in the development of novel antimicrobial therapeutics for cystic fibrosis.
Journal of medical microbiology Dec, 2022 | Pubmed ID: 36748497
Effect of Probiotics in Breast Cancer: A Systematic Review and Meta-Analysis.
Biology Feb, 2023 | Pubmed ID: 36829557
Emerging strategies to target virulence in respiratory infections.
Critical reviews in microbiology Nov, 2023 | Pubmed ID: 37999716
Multi-layered genome defences in bacteria.
Current opinion in microbiology Apr, 2024 | Pubmed ID: 38368839
Exploiting lung adaptation and phage steering to clear pan-resistant Pseudomonas aeruginosa infections in vivo.
Nature communications Feb, 2024 | Pubmed ID: 38378698
Secondary messenger signalling influences Pseudomonas aeruginosa adaptation to sinus and lung environments.
The ISME journal Jan, 2024 | Pubmed ID: 38647527
Ecological and evolutionary mechanisms driving within-patient emergence of antimicrobial resistance.
Nature reviews. Microbiology Oct, 2024 | Pubmed ID: 38689039
Optimization of a DNA extraction protocol for improving bacterial and fungal classification based on Nanopore sequencing.
Access microbiology , 2024 | Pubmed ID: 39376590
JoVE Hakkında
Telif Hakkı © 2020 MyJove Corporation. Tüm hakları saklıdır